Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

ECX vs MLEC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MLEC Captures Overall Composite Edge (40.8 SELL vs 52.4 HOLD), While ECX Leads 4–1 on Growth & Valuation Pillars

MLEC Overall Winner 6-Pillar Tally: ECX 4 – 1 MLEC (1 Tie) Matrix Metrics: ECX 4 – 5 MLEC

As of Nov 19, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over ECARX Holdings Inc. Class A (ECX) on higher Unified Composite conviction (40.8/100 SELL vs. 52.4/100 HOLD) after splitting the core matrix 5–4 (led by Profitability & Quality), while ECX wins 4–1 across the 6-pillar growth and valuation breakdown. ECX trades at $0.69 (12.1x Forward P/E, -4.6% operating margin) versus MLEC at $0.85 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While ECX currently prints a higher short-term Unified Composite Score (52.4/100 HOLD vs. MLEC 40.8/100 SELL), MLEC captures the overall institutional head-to-head verdict (5–4 matrix metrics and 1–4 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -4.6% operating margin) and revenue trajectory (+948.3% vs. +9.5% YoY).
  • Technical & Structure Timing Caution: ECX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile MLEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ECX vs MLEC
ECX NASDAQ
ECARX Holdings Inc. Class A Ordinary shares
Services-Computer Integrated Systems Design
$0.69
-9.78% 1D
Market Cap $300.6M
TTM Revenue $902M
Forward P/E 12.1x
Beta / 30D Vol 0.44β · 122% Vol
Unified Composite Score
52.4 / 100 HOLD
Tech 50.0 Fund 53.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.4%), weak momentum, RSI 39
RSI-14: 38.6 · SMA20: $0.81 · SMA50: $0.90
MLEC NASDAQ Head-to-Head Winner
Moolec Science SA Ordinary Shares
Textile Mill Products
$0.85
-39.29% 1D
Market Cap $1.0M
TTM Revenue $7.8M
Forward P/E N/M
Beta / 30D Vol 0.05β · 208% Vol
Unified Composite Score
40.8 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -30.9%), weak momentum, RSI 17
RSI-14: 16.8 · SMA20: $2.06 · SMA50: $4.58

6-Pillar Scorecard Institutional Category Breakdown (ECX 4 – 1 MLEC)

Columns: Metric · ECX · MLEC
1. Valuation Multiples ECX
Forward P/E 12.1x N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.8x 0.1x
2. Growth & Scale ECX
Revenue Growth (YoY) +9.5% +948.3%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $902M $7.8M
Market Cap $300.6M $1.0M
3. Profitability & Quality MLEC
Gross Margin 15.3% -8.2%
Operating Margin -4.6% 0.0%
Net Profit Margin -7.4% 0.0%
Return on Equity (ROE) -2237.6% -174.7%
4. Balance Sheet & Cash Flow ECX
Cash Generation (TTM) -$22M EBITDA -$8.1M EBITDA
Cash Flow Margin -2.4% EBITDA Mgn -103.1% EBITDA Mgn
Net Cash / Leverage $466M Net Debt $0.70 Book/Sh · -174.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ECX
OpEx & R&D Intensity 19.9% of Rev ($180M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Auto Parts Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ECX (4) vs MLEC (5)
Institutional Metric ECX MLEC Criterion Row Edge
Market Capitalization
Scale
$300.6M $1.0M Larger Scale ECX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
12.1x N/M Lower Multiple ECX
Revenue Growth (YoY)
Growth
+9.5% +948.3% Higher Growth MLEC
Operating Margin (TTM)
Profitability
-4.6% 0.0% Higher Margin MLEC
Net Profit Margin
Profitability
-7.4% 0.0% Higher Margin MLEC
Return on Equity (ROE)
Capital Efficiency
-2237.6% -174.7% Higher ROE MLEC
52-Week Range Position
Momentum
1% ($1–$2) 3% ($0–$23) Stronger Trend MLEC
Beta / 30D Volatility
Risk Regime
0.44β · 122% Vol 0.05β · 208% Vol Lower Realized Risk ECX
Unified Institutional Score
Composite Signal
52.4 / 100 (HOLD) 40.8 / 100 (SELL) Higher Composite ECX
Trailing 12M Revenue (USD)
Operating Scale
$902M $7.8M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
15.3% -8.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.8x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$22M EBITDA ($466M Net Debt) -$8.1M EBITDA ($0.70 Book/Sh · -174.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ECX +99.77 pp
ECX: +17.66% · MLEC: -82.11%
3M Horizon ECX +80.46 pp
ECX: -7.34% · MLEC: -87.8%
6M Horizon ECX +83.62 pp
ECX: -8.18% · MLEC: -91.8%
1Y Horizon MLEC +94.87 pp
ECX: -42.29% · MLEC: +52.58%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period ECX Revenue MLEC Revenue ECX Op. Margin MLEC Op. Margin Margin Leader
Q4 '24 N/A $10M N/A -77.9% MLEC
Q1 '25 $670M N/A -14.7% N/A ECX
Q2 '25 $620M N/A -24.0% N/A ECX
Q3 '25 $880M N/A 1.5% N/A ECX
Q4 '25 $1.22B N/A 3.9% N/A ECX
Q1 '26 $530M N/A -9.9% N/A ECX

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ECX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ECX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MLEC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MLEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ECX Moat Profile Cyclical / Execution-Driven Positioning
Auto Parts Operator
Competes within the Auto Parts value chain with $300.6M market capitalization and -4.6% operating margin.
OpEx & R&D Reinvestment 19.9% of Rev ($180M)
90D Engineering Disclosures 0 Published
MLEC Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ECX vs MLEC Key Questions & Quantitative Answers

As of Nov 19, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over ECARX Holdings Inc. Class A (ECX) on higher Unified Composite conviction (40.8/100 SELL vs. 52.4/100 HOLD) after splitting the core matrix 5–4 (led by Profitability & Quality), while ECX wins 4–1 across the 6-pillar growth and valuation breakdown. ECX trades at $0.69 (12.1x Forward P/E, -4.6% operating margin) versus MLEC at $0.85 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While ECX currently prints a higher short-term Unified Composite Score (52.4/100 HOLD vs. MLEC 40.8/100 SELL), MLEC captures the overall institutional head-to-head verdict (5–4 matrix metrics and 1–4 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -4.6% operating margin) and revenue trajectory (+948.3% vs. +9.5% YoY). Technical & Structure Timing Caution: ECX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile MLEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ECX leads the Growth & Scale pillar: ECX posts +9.5% YoY revenue growth and +0.0% YoY earnings growth on $902M TTM revenue (15.3% gross margin, -4.6% operating margin), compared with MLEC at +948.3% YoY revenue growth and +0.0% YoY earnings growth on $7.8M TTM revenue (-8.2% gross margin, 0.0% operating margin). Across the 6-period historical trajectory (Q4 '24 to Q1 '26), ECX cumulative revenue shifted -20.9% while MLEC shifted N/A. In operating R&D and SG&A reinvestment, ECX deploys 19.9% of Rev ($180M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MLEC.

ECX screens cheaper on headline valuation multiples. ECX trades at 12.1x Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-2.4% EBITDA margin), whereas MLEC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-103.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ECX (-2237.6% ROE) versus MLEC (-174.7% ROE) capital efficiency.

In options market volatility and institutional positioning, ECX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 122% Vol realized risk). By comparison, MLEC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.05β · 208% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.